1Brooker AJ. The essence of SNPs. Gene, 1999,234(2):177～186.
2Shork NJ, Fallin D, Lanchbury S, et al. Single nucleotide polymorphism and the future of genetic epidemiology. Clin Genet,2000, 58: 250～264.
3Taillon-Miller P, Gu Z, Li Q, et al. Overlapping genomic sequences: a treasure trove of single-nucleotide polymorphisms.Genome Res, 1998, 8 (7): 748～754.
4Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 2001, 409 (6822): 928～933.
6Hudson LL, Rocca K, Song YW, et al. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet,2002, 111 (4-5): 452～452.
8Aguilar F, Torres B, Sanchez-Roman J, et al. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus.Hum Immunol, 2003, 64 (10): 936～940.
9Pullmann R Jr, Lukac J, Skerenova M, et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol, 1999, 17(6): 725～729.
10Ahmed S, Ihara K, Kanemitsu S, et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford),2001, 40 (6): 662～667.
二级参考文献85
1Kroeger KM, Carville KS, Abraham LJ, et al. The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription[J]. Mol Immunol, 1997,34:391-399.
2Stuber F, Udalova IA, Book M, et al. 308 tumor necrosis factor(TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter[J]. J Inflamm,1996,46:42-50.
3Louis E, Franchimont D, Piton A, et al. Tumor necrosis factor(TNF)gene polymorphism influences TNF-alpha production in lipopolysaccharide(LPS)-stimulated whole blood cell culture in healthy human[J]. J Clin Exp Immunol,1998,113(3) :401-406.
4Lee SH, Park SH, Min JK, et al. Decreased tumor necrosis factor-beta production in TNFβ * 2 homozygote: an important predisposing factor of lupus nephritis in koreans [J]. Lupus,1997,6(7) :603-609.
5Sullivan KE, Wooten C, Schmechpeper BJ, et al. A promoter polymorphism of tumor necrosis factor a associated with systemic lupus erythematosus in African-Americans [J]. Arthritis Rheumatism, 1997,40(12): 2207.
6Rudwaleit M, Tikly NT, Khamashta M, et al. Interethnic difference in the associated of tumor necrosis factor polymorphism with systemic lupus erythematosus[J]. J Rheumatol, 1996,23:1725-1728.
7Rood MJ, Van-Krugten MV, Zanelli E, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus[J]. Arthritis Rheumatism, 2000,43 (1): 129-134.
8D' Alfonso S, Colombo G, Della BS, et al. Associated between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population[J]. Tissue Antigen, 1996,47:551-555.
9Kim TG, Kim HY, Lee SH, et al. Systemic lupus erythematosus with nephritis is strongly associated with TNFβ homozygote in the human population[J]. Hum Immunol,1996,46:10-17.
10Zhang J, Zhou F, Ai R,et al. Study on some susceptible genes of systemic lupus erythematosus in Han nationality of China[J]. Chung Hua Nei Ko Tsa Chih, 1996,35(1):19-22.
1Van d er Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum, 1984, 27: 361-368.
2Boumah CE, Meyer B, Aljurf M,et al. Monitoring of donor/ recipient T-cell engraftment kinetics in myeloablative allogeneic stem cell transplantation using short tandem repeat amplification from cell lysates. Leuk Lymphoma, 2002, 43: 1281-1287.
3Jankowski S, Cuttle-Fraser E, Xu L, et al. Multiplex ligationdependent probe amplification analysis on capillary electrophore- sis instruments for a rapid gene copy number study. J Biomol Tech. 2008, 19: 238-243.
4Maksymowycb WP, Rahman P, Reeve JP, et al. Association of the IL-1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum, 2006, 54: 974-985.
5Timms AE, Crane AM, Sims AM, et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet, 2004, 75 : 587-595.
6Milicic A, Lindheimer F, Laval S,et al.Interethnie studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis.Genes Immunol, 2000, 1: 418-422.
7Vargas-Alarcon G, Casasola-Vargas J, Rodriguez-Perez JM, et al.Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol, 2006, 67 : 826-832.
8Georgia H, Ira M, Jun T, et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B ceils and involved in chromosome 1q21 abnormalities in B cell malignancy.Immunity, 2001, 14: 277-289.
9Yasuhiro N, Sherman MW, Alfred LMB. BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells. Biochem Biophys Res Commun, 2001, 285: 830-837.
10Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FcRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet, 2005, 37: 478-485.
